Utilization of LDN in the Pediatric Population

31 min
Handout: https://bit.ly/4eG3KA7

During this session, Trcia Heitman, PharmD, will discuss why low dose naltrexone (LDN) is a good therapeutic option in pediatric autoimmune disease, the literature available supporting the use of LDN in children, the possible options for the use of LDN in children, and understand the marketing challenges and addrfessing fear that parents of practitioners may have regarding compounded LDN treatment.